stoxline Quote Chart Rank Option Currency Glossary
  
Aura Biosciences, Inc. (AURA)
8.525  -0.195 (-2.24%)    10-07 14:20
Open: 8.67
High: 8.67
Volume: 27,439
  
Pre. Close: 8.72
Low: 8.38
Market Cap: 423(M)
Technical analysis
2024-10-07 2:11:37 PM
Short term     
Mid term     
Targets 6-month :  11.07 1-year :  12.67
Resists First :  9.47 Second :  10.85
Pivot price 9.02
Supports First :  7.26 Second :  6.04
MAs MA(5) :  8.64 MA(20) :  9.16
MA(100) :  8.16 MA(250) :  8.16
MACD MACD :  0 Signal :  0.1
%K %D K(14,3) :  7.6 D(3) :  8.4
RSI RSI(14): 44.1
52-week High :  12.35 Low :  5.98
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ AURA ] has closed above bottom band by 12.9%. Bollinger Bands are 14.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 8.88 - 8.93 8.93 - 8.98
Low: 8.47 - 8.53 8.53 - 8.59
Close: 8.61 - 8.71 8.71 - 8.82
Company Description

Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develops AU-011 in additional ocular oncology indications, including choroidal metastases. The company was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.

Headline News

Fri, 04 Oct 2024
Aura Biosciences, Inc. (NASDAQ:AURA) is a favorite amongst institutional investors who own 58% - Yahoo Finance

Sat, 28 Sep 2024
Ensign Peak Advisors Inc Sells 105,316 Shares of Aura Biosciences, Inc. (NASDAQ:AURA) - MarketBeat

Fri, 27 Sep 2024
Wall Street SWOT: Aura Biosciences stock shows promise amid cancer treatment trials - Investing.com

Fri, 27 Sep 2024
Aura Biosciences Executives Transition and Compensation Update - TipRanks

Tue, 17 Sep 2024
Aura Biosciences: Highly Derisked Late Stage Eye Cancer Company (NASDAQ:AURA) - Seeking Alpha

Thu, 12 Sep 2024
Aura Biosciences Touts Promising Data From Eye Cancer Candidate - Benzinga

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 50 (M)
Shares Float 34 (M)
Held by Insiders 5 (%)
Held by Institutions 79.9 (%)
Shares Short 1,310 (K)
Shares Short P.Month 1,230 (K)
Stock Financials
EPS -1.79
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 3.85
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -27.5 %
Return on Equity (ttm) -45.1 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -1.8
Qtrly Earnings Growth 0 %
Operating Cash Flow -73 (M)
Levered Free Cash Flow -47 (M)
Stock Valuations
PE Ratio -4.73
PEG Ratio 0
Price to Book value 2.18
Price to Sales 0
Price to Cash Flow -5.72
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android